Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid February Same-Store Sales Rose 3.1%; Up 3% In 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:07pm CET

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.1% in February, marking the 11th straight month of growth for the drug store chain.

The No. 3 U.S. drug store chain behind Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month last year -- March had a 0.1% drop -- with a boost from the rollout of a loyalty program and store renovations that expanded clinical pharmacy services and health and wellness products choices.

During February, same-store sales were up 1.9% in the front of the store. Pharmacy same-store sales increased 3.7%, despite a negative impact of 2.42 percentage points from generic drug introductions. Same-store prescription counts were up 2.2%.

For the fiscal fourth quarter ended March 3, same-store sales improved 3%, including growth of 1.6% in the front of the store and 3.8% in the pharmacy section.

Total February drug store sales rose 2.3% to $2.55 billion. Prescription sales accounted for 68.3% of drugstore sales.

For the quarter, total drug store sales rose 2.5% to $7.12 billion.

Rite-Aid, which has about 4,667 stores, has posted losses since its 2007 acquisition of the Brooks Eckerd Pharmacy chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed as same-store sales grew for a fourth consecutive quarter and interest expense and lease termination and write-down charges declined.

Shares were up 1.2% at $1.71 in recent premarket trading. Through Wednesday's close, the stock is up by slightly more than a third this year.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
12/01 MARCUS & MILLICHAP : Rite Aid in Midlothian sells for $3.4 million
12/01 RITE AID : McQueary unable to get a job at Rite Aid, and other key points by the..
11/29 RITE AID : Police arrest man after failed "bomb" robbery
11/25 RITE AID : Hackensack Meridian opening Rite Aid clinics
11/22 RITE AID : Customers Can Now Use American Express® Membership Rewards® Points fo..
11/22 RITE AID : Easton addict who robbed 3 stores gets up to 8 years
11/21 RITE AID : Presents Black Friday Shoppers With Lowest Offers of the Year
11/21 ALBERTSONS : May Acquire Rite Aid's Stores from Walgreen
11/19 RITE AID : Police searching for five suspected Rite Aid thieves
11/17 RITE AID : Former Rite Aid Vice President And New Jersey Businessman Sentenced T..
More news
Sector news : Retail - Drugs without Grocery
11/16DJTarget Draws Back Shoppers
11/16DJWALGREENS BOOTS ALLIANCE : Claims Theranos Voided 11.3% of Test Reports
11/10 Trump victory clouds outlook for Time Warner-AT&T, other mergers
11/09 Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
11/09DJWALGREENS BOOTS ALLIANCE : Walgreen Sues Theranos, Seeking to Recover $140 Milli..
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
11/29 No Stopping The Rally? Cramer's Mad Money (11/28/16)
11/25 Black Friday (Arb) Bargains
11/22 The Superior Investment For Next Decade - Walgreens Boots Alliance Or CVS?
11/22 Tracking David Einhorn's Portfolio - Q3 2016 Update
11/21 Buffett's Berkshire Flies
Advertisement
Financials ($)
Sales 2017 32 800 M
EBIT 2017 676 M
Net income 2017 126 M
Debt 2017 6 848 M
Yield 2017 -
P/E ratio 2017 63,37
P/E ratio 2018 42,83
EV / Sales 2017 0,47x
EV / Sales 2018 0,44x
Capitalization 8 428 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 8,69 $
Spread / Average Target 8,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION1.79%8 428
RAIA DROGASIL SA75.91%5 867
AIN HOLDINGS INC36.41%2 199
ORIOLA KD OYJ1.16%821
AUSTRALIAN PHARMACEUTI..0.78%681
ADCOCK INGRAM HOLDINGS..-6.35%581
More Results